Flexeril (cyclobenzaprine) is not an antidepressant. It is a muscle relaxant prescribed for short-term relief of muscle spasms associated with acute musculoskeletal pain. However, the confusion is understandable: cyclobenzaprine is chemically almost identical to tricyclic antidepressants like amitriptyline, and the FDA’s own labeling describes it as “closely related” to that drug class.
Why Flexeril Looks Like an Antidepressant
Cyclobenzaprine belongs to a chemical family called tricyclic amines, the same family that includes the classic antidepressants amitriptyline and imipramine. All three drugs share a three-ringed molecular backbone. The structural difference between cyclobenzaprine and amitriptyline is minor: just one double bond in the central ring. That tiny change shifts the drug’s primary effect from mood regulation to muscle relaxation.
Because of this shared chemistry, cyclobenzaprine produces many of the same side effects you’d expect from a tricyclic antidepressant: drowsiness, dry mouth, dizziness, and constipation. These are anticholinergic effects, and they’re a hallmark of the tricyclic class regardless of whether the specific drug is used for depression or muscle spasms.
How Flexeril Actually Works
Rather than acting on mood circuits, cyclobenzaprine works primarily in the brainstem. It increases the brainstem’s ability to dampen nerve signals traveling down to the spinal cord, which reduces the excessive muscle firing that causes spasms. Specifically, it boosts a type of nerve signaling that quiets motor neurons controlling muscle tone. The result is that tight, spasming muscles relax, not because the drug acts on the muscle itself, but because the brain turns down the volume on the signals telling those muscles to contract.
This is fundamentally different from what antidepressants do. Tricyclic antidepressants work by increasing levels of serotonin and norepinephrine in brain circuits that regulate mood. While cyclobenzaprine also influences norepinephrine pathways, it does so in a way that targets motor activity rather than emotional processing. It has no FDA-approved use for depression, anxiety, or any psychiatric condition.
Why the Distinction Matters for Drug Interactions
Even though Flexeril isn’t an antidepressant, it interacts with the same brain chemistry that antidepressants affect. This creates real risks if you take both at the same time. The most serious concern is serotonin syndrome, a potentially life-threatening reaction that occurs when too much serotonin accumulates in the nervous system. Symptoms include confusion, agitation, rapid heart rate, unstable blood pressure, muscle rigidity, tremor, and high body temperature.
The FDA has flagged serotonin syndrome risk when Flexeril is combined with SSRIs (like sertraline or fluoxetine), SNRIs (like duloxetine or venlafaxine), tricyclic antidepressants, tramadol, bupropion, and several other medications. The interaction with MAO inhibitors is especially dangerous. Cyclobenzaprine is completely contraindicated with MAO inhibitors or within 14 days of stopping one, because the combination has caused seizures, dangerously high fevers, and deaths.
If you’re already taking an antidepressant and your doctor prescribes Flexeril for a muscle injury, the two medications can often be used together with careful monitoring. But the combination requires awareness of serotonin syndrome symptoms so you can recognize them early.
How Flexeril Is Meant to Be Used
The FDA recommends cyclobenzaprine for short periods only, typically two to three weeks. This is partly because muscle spasms from acute injuries tend to resolve in that timeframe, and partly because there isn’t strong evidence that the drug remains effective beyond a few weeks. This short treatment window is another key difference from antidepressants, which are typically taken for months or years.
Cyclobenzaprine has also been studied for fibromyalgia, where it has shown some benefit for musculoskeletal pain and sleep disturbances. This off-label use sometimes adds to the confusion about what the drug is “for,” since fibromyalgia overlaps with conditions that antidepressants also treat. But even in fibromyalgia research, cyclobenzaprine is being used for its muscle-relaxing and sleep-promoting properties, not for any antidepressant effect.
The Bottom Line on Classification
Flexeril is a muscle relaxant that happens to be built on the same chemical scaffold as tricyclic antidepressants. It shares their side effect profile, their drug interaction risks, and their general “feel” as a sedating medication. But it does not treat depression, is not classified as an antidepressant, and works on a different set of targets in the brain. If you’ve noticed the chemical similarity on a drug reference site or pharmacy printout, you’re reading it correctly. The molecules are close cousins. Their jobs, however, are distinct.